Zamora Ismael, Afzelius Lovisa, Cruciani Gabriele
Drug Metabolism, Pharmacokinetic and Bioanalytical Chemistry, AstraZeneca R&D Mölndal, Sweden.
J Med Chem. 2003 Jun 5;46(12):2313-24. doi: 10.1021/jm021104i.
The aim of the present study is to develop a method for predicting the site at which molecules will be metabolized by CYP 2C9 (cytochrome P450 2C9) using a previously reported protein homology model of the enzyme. Such a method would be of great help in designing new compounds with a better pharmacokinetic profile, or in designing prodrugs where the compound needs to be metabolized in order to become active. The methodology is based on a comparison between alignment-independent descriptors derived from GRID Molecular Interaction Fields for the CYP 2C9 active site, and a distance-based representation of the substrate. The predicted site of metabolism is reported as a ranking list of all the hydrogen atoms of each substrate molecule. Eighty-seven CYP 2C9-catalyzed oxidative reactions reported in the literature have been analyzed. In more than 90% of these cases, the hydrogen atom ranked at the first, second, or third position was the experimentally reported site of oxidation.
本研究的目的是利用先前报道的该酶的蛋白质同源模型,开发一种预测分子将被细胞色素P450 2C9(CYP 2C9)代谢的位点的方法。这种方法将极大地有助于设计具有更好药代动力学特征的新化合物,或设计需要代谢才能变得活跃的前药。该方法基于对源自CYP 2C9活性位点的GRID分子相互作用场的非比对描述符与底物的基于距离的表示之间的比较。预测的代谢位点报告为每个底物分子所有氢原子的排名列表。对文献中报道的87个CYP 2C9催化的氧化反应进行了分析。在超过90%的这些案例中,排名第一、第二或第三的氢原子是实验报道的氧化位点。